RxDoctor Payments Data

Emily Hall, NP

Family · Dalton, GANPI 1326310756

Payments from drug & device makers

$4,135in general payments, 2019–2025

Across 181 payments — averaging $22.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$982
  • AbbVie$708
  • Lilly USA, LLC$388
  • Regeneron Healthcare Solutions, Inc.$320
  • E.r. Squibb & Sons, L.L.C.$302
  • Sun Pharmaceutical Industries Inc.$283
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,85793%
  • Education$2787%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,135 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$167,559
Medicare patients
692
Services billed
4,450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Unoready PenSecukinumab16$134,285
Taltz AutoinjectorIxekizumab18$115,452
Dupixent PenDupilumab13$62,515
OtezlaApremilast11$49,949
Clobetasol Propionate103$3,516
Ketoconazole120$2,374
Triamcinolone Acetonide116$1,980
Doxycycline Hyclate103$1,617
Metronidazole13$1,000
Nystatin15$512
Ammonium Lactate20$409
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim28$393
Minocycline Hcl15$338
Minoxidil23$265
Cephalexin35$210

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$91$49,94911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.

Other family in Dalton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →